Notably, future studies should explore healthy experimental controls involving the hUC‐MSC secretome's ability to reverse pro‐inflammatory cytokine profiles in CD4+ T cells, as well as different treatment modalities that inhibit glucose metabolism in SLE. Here, CD4 is linked to systemic lupus erythematosus.